• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-130a-3p 的差异表达调控卵巢上皮性癌(OEC)细胞的发生发展,有望成为 OEC 的一种新型生物标志物。

Differential expression of miR-130a-3p modulate ovarian epithelial carcinoma (OEC) cell development and could be a biomarker for OEC.

机构信息

Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.

Department of Medical-Surgical Nursing, College of Nursing, King Saud University, Riyadh, Saudi Arabia.

出版信息

J Reprod Immunol. 2021 Jun;145:103310. doi: 10.1016/j.jri.2021.103310. Epub 2021 Mar 10.

DOI:10.1016/j.jri.2021.103310
PMID:33730656
Abstract

A lot of research investigations, conducted in the recent years, establishes that microRNAs (miRNAs) have an important role in keeping both growth and metastasis of Ovarian Epithelial Carcinoma (OEC) under control. However, the clinical and functional role of miR-130a-3p in OEC is yet to be explored. Through quantitative reaction i.e., qRT-PCR, the expression of miR-130a-3p was assessed in tissues and cell lines of OEC patients. This analysis determined the relationship between the expression of miR-130a-3p and its clinicopathology with the overall survival rate of OEC patients. The author made use of cell counting analysis (CCK8) and in vitro flow cytometry to understand the functional and biological impact of miR-130a-3p expression. In comparison with neighboring normal tissues, the expression of miR-130a-3p was found to be lower in 7 OEC samples. Few reasons are cited for this scenario i.e., low expression of miR-130a-3p, such as low overall OEC patient survival rate, incidence of FIGO and metastasis of lymph nodes. miR-130a-3p has been found as an independent candidate for predicting the prognosis of OEC patients, as per Multivariate Cox research. When miR-130a-3p is over-expressed, as per the enhanced mechanism, it prevents both cell proliferation and cell cycle production in OEC. The current study findings emphasize that miR-130a-3p can be leveraged as a biomarker of prognosis and possibly as a target in the treatment of OEC.

摘要

近年来,大量研究表明,微小 RNA(miRNAs)在控制卵巢上皮性癌(OEC)的生长和转移方面起着重要作用。然而,miR-130a-3p 在 OEC 中的临床和功能作用仍有待探索。通过定量反应,即 qRT-PCR,评估了 OEC 患者组织和细胞系中 miR-130a-3p 的表达。该分析确定了 miR-130a-3p 的表达与其临床病理学与 OEC 患者总生存率之间的关系。作者利用细胞计数分析(CCK8)和体外流式细胞术来了解 miR-130a-3p 表达的功能和生物学影响。与邻近的正常组织相比,在 7 个 OEC 样本中发现 miR-130a-3p 的表达较低。造成这种情况的原因有几个,例如 miR-130a-3p 表达低,总 OEC 患者生存率低,FIGO 发生率和淋巴结转移。根据多变量 Cox 研究,miR-130a-3p 被认为是预测 OEC 患者预后的独立候选者。根据增强机制,当 miR-130a-3p 过表达时,它可以防止 OEC 中的细胞增殖和细胞周期产生。本研究结果强调,miR-130a-3p 可以作为预后的生物标志物,并可能作为 OEC 治疗的靶点。

相似文献

1
Differential expression of miR-130a-3p modulate ovarian epithelial carcinoma (OEC) cell development and could be a biomarker for OEC.miR-130a-3p 的差异表达调控卵巢上皮性癌(OEC)细胞的发生发展,有望成为 OEC 的一种新型生物标志物。
J Reprod Immunol. 2021 Jun;145:103310. doi: 10.1016/j.jri.2021.103310. Epub 2021 Mar 10.
2
lncRNA MIAT Regulates Cell Growth, Migration, and Invasion Through Sponging miR-150-5p in Ovarian Cancer.长链非编码 RNA MIAT 通过海绵吸附 miR-150-5p 调控卵巢癌细胞的生长、迁移和侵袭。
Cancer Biother Radiopharm. 2020 Nov;35(9):650-660. doi: 10.1089/cbr.2019.3259. Epub 2020 Mar 18.
3
miRNA expression profile changes in the peripheral blood of monozygotic discordant twins for epithelial ovarian carcinoma: potential new biomarkers for early diagnosis and prognosis of ovarian carcinoma.miRNA 表达谱在单侧卵巢癌单卵双胞胎外周血中的变化:卵巢癌早期诊断和预后的潜在新生物标志物。
J Ovarian Res. 2020 Aug 27;13(1):99. doi: 10.1186/s13048-020-00706-8.
4
Downregulation of miR-1294 associates with prognosis and tumor progression in epithelial ovarian cancer.miR-1294 的下调与上皮性卵巢癌的预后和肿瘤进展相关。
Eur Rev Med Pharmacol Sci. 2018 Nov;22(22):7646-7652. doi: 10.26355/eurrev_201811_16381.
5
Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway.环状 RNA(circRNA)-PGAM1 通过调控 miR-542-3p/CDC5L/PEAK1 通路促进上皮性卵巢癌的恶性进展。
Cancer Med. 2020 May;9(10):3500-3521. doi: 10.1002/cam4.2929. Epub 2020 Mar 13.
6
miR‑508‑3p suppresses the development of ovarian carcinoma by targeting CCNA2 and MMP7.miR-508-3p 通过靶向 CCNA2 和 MMP7 抑制卵巢癌的发展。
Int J Oncol. 2020 Jul;57(1):264-276. doi: 10.3892/ijo.2020.5055. Epub 2020 Apr 27.
7
HDAC3 increases HMGB3 expression to facilitate the immune escape of breast cancer cells via down-regulating microRNA-130a-3p.组蛋白去乙酰化酶 3 通过下调 microRNA-130a-3p 增加高迁移率族蛋白 B3 的表达,促进乳腺癌细胞的免疫逃逸。
Int J Biochem Cell Biol. 2021 Jun;135:105967. doi: 10.1016/j.biocel.2021.105967. Epub 2021 Mar 13.
8
Role of hsa‑miR‑105 during the pathogenesis of paclitaxel resistance and its clinical implication in ovarian cancer.hsa-miR-105 在紫杉醇耐药发病机制中的作用及其在卵巢癌中的临床意义。
Oncol Rep. 2021 May;45(5). doi: 10.3892/or.2021.8035. Epub 2021 Apr 13.
9
Over-expression of RALYL suppresses the progression of ovarian clear cell carcinoma through inhibiting MAPK and CDH1 signaling pathways.RALYL 的过表达通过抑制 MAPK 和 CDH1 信号通路抑制卵巢透明细胞癌的进展。
Int J Med Sci. 2021 Jan 1;18(3):785-791. doi: 10.7150/ijms.51488. eCollection 2021.
10
MiR-337-3p suppresses proliferation of epithelial ovarian cancer by targeting PIK3CA and PIK3CB.miR-337-3p 通过靶向 PI3KCA 和 PI3KCB 抑制上皮性卵巢癌细胞的增殖。
Cancer Lett. 2020 Jan 28;469:54-67. doi: 10.1016/j.canlet.2019.10.021. Epub 2019 Oct 17.